Worth Venture Partners »

Inotiv shares owned by Worth Venture Partners

Quarter-by-quarter ownership of Inotiv (NOTV) shares owned by Worth Venture Partners from 13F filings

Historical chart of Worth Venture Partners investment in Inotiv

Tip: Access up to 7 years of quarterly data

All positions including Inotiv held by Worth Venture Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inotiv by Worth Venture Partners

Quarter filed Position value Share count Share price at filing
2024-03-31 $148k 14k 10.94

More positions owned by Worth Venture Partners

Johnson & Johnson (JNJ)
Arteris (AIP)
Ishares Tr U.s. Med Dvc Etf (IHI)
Iteris (ITI)
Weave Communications (WEAV)
Shotspotter (SSTI)
Radcom Shs New (RDCM)
Cto Realty Growth (CTO)
Apellis Pharmaceuticals (APLS)
Insmed Com Par $.01 (INSM)
Sarepta Therapeutics Call Call Option
Novo-nordisk A S Adr (NVO)
Egain Corp Com New (EGAN)
Whitestone REIT (WSR)
Equity Comwlth Com Sh Ben Int (EQC)

View all positions for Worth Venture Partners

Top funds holding Inotiv

Vanguard Group
Millennium Management
Ameriprise Financial
Goldman Sachs Group
Geode Capital Management
Two Sigma Investments
BlackRock
Man Group
Susquehanna International
Citadel Advisors
Marshall Wace
D. E. Shaw & Co
Oak Family Advisors
Rice Hall James & Associates
American Century Companies

View all funds holding Inotiv